bullish

Natco Pharma

Natco Pharma Limited: Sequential Domestic Recovery Amid Covid Sales

101 Views16 Aug 2021 10:59
Broker
What should investors do? Natco's share price has grown by ~1.6x over the past five years (from ~Rs 632 in July 2016 to ~Rs 1024 levels in July 2021). We retain our HOLD rating on this stock...
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
ICICI Securities Limited
External broker reports(aggregated public sources)
ICICI Securities Ltd
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Natco Pharma Limited: Sequential Domestic Recovery Amid Covid Sales
    16 Aug 2021
x